Treating nightmares in post-traumatic stress disorder with the α-adrenergic agents clonidine and doxazosin: protocol for a phase II randomised, double-blind, placebo-controlled parallel-group study (ClonDoTrial)
Authors
Christoph Mulert (ORCID: https://orcid.org/0000-0001-8214-5868)
Treating nightmares in post-traumatic stress disorder with the α-adrenergic agents clonidine and doxazosin: protocol for a phase II randomised, double-blind, placebo-controlled parallel-group study (ClonDoTrial)
Christoph Mulert, Stefanie Koglin, Christian Otte, Karl Stieglbauer et al.
Citations
1 citations
Journal
BMJ Open
Topics
Posttraumatic Stress Disorder Research
Field-Weighted Citation Impact (FWCI)
2.31
article
Treating nightmares in post-traumatic stress disorder with the α-adrenergic agents clonidine and doxazosin: protocol for a phase II randomised, double-blind, placebo-controlled parallel-group study (ClonDoTrial)
Christoph Mulert, Stefanie Koglin, Christian Otte, Karl Stieglbauer, Kathlen Priebe, Sarah V. Biedermann, Stefan Roepke, Christian Schmahl, Ingo Schaefer, Tolou Maslahati, Nikola Schoofs, Andreas J. Fallgatter, Bernd Hanewald, Thomas Ethofer, Robert Roehle, Jürgen Gallinat, Felix Wuelfing
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(8)
Institutions
Universität Hamburg (DE), Heidelberg University (DE), Universitätsklinikum Gießen und Marburg (DE), University Hospital Heidelberg (DE), Humboldt-Universität zu Berlin (DE), Universitätsklinikum Tübingen (DE), Central Institute of Mental Health (DE), University Medical Center Hamburg-Eppendorf (DE)